Your browser doesn't support javascript.
loading
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
Santoni, Matteo; Molina-Cerrillo, Javier; Myint, Zin W; Massari, Francesco; Buchler, Tomas; Buti, Sebastiano; Matrana, Marc R; De Giorgi, Ugo; Rizzo, Mimma; Zabalza, Ignacio Ortego; Galli, Luca; Zucali, Paolo Andrea; Aurilio, Gaetano; Incorvaia, Lorena; Bassanelli, Maria; Mammone, Giulia; Salfi, Alessia; Isella, Luca; Mollica, Veronica; Grande, Enrique; Porta, Camillo; Battelli, Nicola.
Affiliation
  • Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.
  • Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.
  • Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, Bologna, Italy. francesco.massari@aosp.bo.it.
  • Buchler T; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy. francesco.massari@aosp.bo.it.
  • Buti S; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.
  • Matrana MR; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • De Giorgi U; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Rizzo M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Zabalza IO; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Galli L; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Zucali PA; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy.
  • Aurilio G; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Incorvaia L; Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Bassanelli M; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Mammone G; Department of Medical and Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
  • Salfi A; Department of Radiological, Oncological and Anatomo-Pathological Science, "Sapienza" University of Rome, Rome, Italy.
  • Isella L; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy.
  • Mollica V; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Grande E; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, Bologna, Italy.
  • Porta C; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
  • Battelli N; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
Target Oncol ; 17(5): 571-581, 2022 09.
Article in En | MEDLINE | ID: mdl-35947324
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Kidney Neoplasms / Metformin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Kidney Neoplasms / Metformin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Italy